MedTrace Logo

A Prospective, Single-arm, Multi-centre, Observational, Real World Registry

NCT02901353 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2020-02-21

No results posted yet for this study

Summary

A prospective, single-arm, multi-centre, observational, real world registry to evaluate safety and performance of the BioMime™ Morph Sirolimus Eluting Coronary Stent System for very long coronary lesions.

Conditions

  • Angina Pectoris

Interventions

DEVICE

Sirolimus Eluting Coronary Stent System

Patient with Angina Pectoris will be enrolled for the intervention

Sponsors & Collaborators

  • Meril Life Sciences Pvt. Ltd.

    lead INDUSTRY

Principal Investigators

  • Prof. Dr. Bela Merkely, MD, Ph.D, D.Sc · University of Semmelweis

  • Dr. Szűk Tibor, Ph.D, MD · University of Debrecen

  • Dr. P. Agostoni, Ph.D, MD · St. Antonius Nieuwegein

  • Dr. Imad A Haddad, MD · Jordan Hospital

  • Dr. Ramesh Singh, MBBS, MRCP · University Malaya Medical Centre (UMMC)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-02
Primary Completion
2020-12-01
Completion
2022-12-01

Countries

  • Hungary
  • Jordan
  • Malaysia
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02901353 on ClinicalTrials.gov